Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 587-594, January 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leyland-Jones, B. R.
Right arrow Articles by Goldsmith, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leyland-Jones, B. R.
Right arrow Articles by Goldsmith, M. E.

Antineoplastic Drug Sensitivity of Human MCF-7 Breast Cancer Cells Stably Transfected with a Human {alpha} Class Glutathione S-Transferase Gene

Brian R. Leyland-Jones1, Alan J. Townsend2, Chen-Pei D. Tu, Kenneth H. Cowan3 and Merrill E. Goldsmith

Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 [B. R. L.-J., A. J. T., K. H. C., M. E. G.], and Department of Molecular and Cell Biology, The Pennsylvania State University, University Park, Pennsylvania 16802 [C.-P. D. T.]

Studies have suggested that the {alpha} class glutathione S-transferase (GST) may protect cells from the chemotherapeutic drugs chlorambucil and melphalan. In order to further define the function of human {alpha} class GST, a complementary DNA which encodes it was ligated into an expression vector under the direction of the human metallothionein-IIA promoter and stably transfected into human MCF-7 breast cancer cells in conjunction with the G418-selectable plasmid pSV2neo. Clonal cell lines were identified which expressed increased levels of GST enzyme activity (2.2- to 5.6-fold). The transfected cell lines also had increased peroxidase activity using cumene hydroperoxide as the substrate (1.9- to 3.8-fold) which is consistent with the intrinsic peroxidase activity of {alpha} class GSTs. Southern blot analysis indicated that genomic DNA from these cells contained a fragment indistinguishable from the transfected {alpha} class GST complementary DNA (850 base pairs); Northern blot analysis of total cellular RNA indicated that these cells contained appropriately sized {alpha} class GST RNA (980 nucleotides); and Western blot analysis indicated that, while MCF-7 cells contained no detectable {alpha} class GST protein, the transfected cells contained markedly elevated levels of {alpha} class GST but no detectable µ or {pi} class GST. These {alpha} class GST transfected cells had increased resistance to ethacrynic acid (2.1- to 3.0-fold). However, the transfected cells failed to show any increased resistance measured at the drug dosage which inhibited 50% of the colony formation to the chemotherapeutic drugs chlorambucil, melphalan, Adriamycin, or cisplatin under conditions of either continuous or 1-h drug exposure. Neither was there any change in sensitivity to the cytotoxins benzo(a)pyrene, benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide (anti), or 1-chloro-2,4-dinitrobenzene. These studies indicate that expression of this human {alpha} class GST by itself in MCF-7 human breast cancer cells does not confer resistance to the chemotherapeutic drugs tested under the conditions used in these studies.

1 Present address: Department of Oncology, McGill University, Montreal, PQ, Canada H3G1Y6.

2 Present address: Department of Biochemistry, Bowman-Gray School of Medicine, Winston-Salem, NC 27127.

3 To whom requests for reprints should be addressed, at Medicine Branch, National Cancer Institute, National Institutes of Health, Bldg. 10, Rm. 12N226, Bethesda, MD 20892.

Received 8/ 3/90. Accepted 11/ 1/90.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. K. Smitherman, A. J. Townsend, T. E. Kute, and C. S. Morrow
Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zembutsu, Y. Ohnishi, T. Tsunoda, Y. Furukawa, T. Katagiri, Y. Ueyama, N. Tamaoki, T. Nomura, O. Kitahara, R. Yanagawa, et al.
Genome-wide cDNA Microarray Screening to Correlate Gene Expression Profiles with Sensitivity of 85 Human Cancer Xenografts to Anticancer Drugs
Cancer Res., January 1, 2002; 62(2): 518 - 527.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Panasci, J.-P. Paiement, G. Christodoulopoulos, A. Belenkov, A. Malapetsa, and R. Aloyz
Chlorambucil Drug Resistance in Chronic Lymphocytic Leukemia: The Emerging Role of DNA Repair
Clin. Cancer Res., March 1, 2001; 7(3): 454 - 461.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. S. Morrow, P. K. Smitherman, S. K. Diah, E. Schneider, and A. J. Townsend
Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. MECHANISM OF GST A1-1- AND MRP1-ASSOCIATED RESISTANCE TO CHLORAMBUCIL IN MCF7 BREAST CARCINOMA CELLS
J. Biol. Chem., August 7, 1998; 273(32): 20114 - 20120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.